Randomized multi center study comparing nephrotoxicity of ceftazidime versus the combination of piperacillin and netilmicin with and without furosemide.
Mondorf
A W
AW
Zentrum der Inneren Medizin der Universitatskliniken Frankfurt, FRG.
Bonsiepe
C
C
Mondorf
W
W
D000368:Aged; D000410:Alanine Transaminase / Q000652:urine; D002442:Ceftazidime / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D004338:Drug Combinations; D005260:Female; D005665:Furosemide / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000201:enzymology / Q000503:physiopathology; D007684:Kidney Tubules / Q000187:drug effects / Q000201:enzymology; D008297:Male; D015337:Multicenter Studies as Topic; D009428:Netilmicin / Q000009:adverse effects*; D010878:Piperacillin / Q000009:adverse effects*; D011897:Random Allocation; D013997:Time Factors
D004338:Drug Combinations; D009428:Netilmicin; D005665:Furosemide; D002442:Ceftazidime; D003404:Creatinine; D000410:Alanine Transaminase; D010878:Piperacillin